Changyi Quan
-
- Epigenetics and DNA Methylation 5
- Ubiquitin and proteasome pathways 3
- Urology top 10%
- Urological Disorders and Treatments 5
- Urinary Bladder and Prostate Research 3
-
- Prostate Cancer Treatment and Research 5
- Ferroptosis and cancer prognosis 4
- Renal cell carcinoma treatment 2
-
- Bladder and Urothelial Cancer Treatments 7
- Co-authors
- Wun‐Jae KimPildu JeongJiyeon KimSuk‐Chul BaeEun‐Jung KimHyung-Lae LeeKeon Myung LeeEun‐Jong Cha
- Partner nations
- ChinaSouth KoreaUnited States
In The Last Decade
Changyi Quan
29 papers receiving 589 citations
Peers
Comparison fields: 5 of 68
- Cancer Research 124
- Molecular Biology 438
- Urology 30
- Pulmonary and Respiratory Medicine 152
- Oncology 96
Countries citing papers authored by Changyi Quan
This map shows the geographic impact of Changyi Quan's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Changyi Quan with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Changyi Quan more than expected).
Fields of papers citing papers by Changyi Quan
This network shows the impact of papers produced by Changyi Quan. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Changyi Quan. The network helps show where Changyi Quan may publish in the future.
Co-authorship network
The 25 scholars most cited alongside Changyi Quan, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2025 | 1 | |
| 2 | 2025 | 0 | |
| 3 | 2024 | 1 | |
| 4 | 2024 | 1 | |
| 5 | 2023 | 6 | |
| 6 | 2023 | 5 | |
| 7 | 2023 | 3 | |
| 8 | 2022 | 0 | |
| 9 | 2021 | 2 | |
| 10 | 2021 | 7 | |
| 11 | 2020 | 12 | |
| 12 | 2020 | 6 | |
| 13 | 2019 | 2 | |
| 14 | 2019 | 2 | |
| 15 | 2019 | 17 | |
| 16 | 2013 | 7 | |
| 17 | 2012 | 62 | |
| 18 | 2011 | 15 | |
| 19 | 2009 | 2 | |
| 20 | 2005 | 102 |
About Changyi Quan
Changyi Quan is a scholar working on Urology, Pulmonary and Respiratory Medicine and Molecular Biology, having authored 32 papers that have together received 592 indexed citations. Recurring topics across this work include Bladder and Urothelial Cancer Treatments (7 papers), Epigenetics and DNA Methylation (5 papers), Urological Disorders and Treatments (5 papers), Prostate Cancer Treatment and Research (5 papers), Ferroptosis and cancer prognosis (4 papers), Ubiquitin and proteasome pathways (3 papers), Urinary Bladder and Prostate Research (3 papers) and Renal cell carcinoma treatment (2 papers). The work is most often cited by research in Cancer Research (124 citations), Molecular Biology (438 citations) and Urology (30 citations). Changyi Quan has collaborated with scholars based in China, South Korea and United States. Frequent co-authors include Wun‐Jae Kim, Pildu Jeong, Jiyeon Kim, Suk‐Chul Bae, Eun‐Jung Kim, Hyung-Lae Lee, Keon Myung Lee, Eun‐Jong Cha, Suk-Chul Bae and Yoshiaki Ito.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.